A general process for the development of peptide-based immunoassays for monoclonal antibodies

PURPOSE: Monoclonal antibodies (mAb) are an important and growing class of cancer therapeutics, but pharmacokinetic analyses have in many cases been constrained by the lack of standard and robust pharmacologic assays. The goal of this project was to develop a general method for the production of imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez, Ana B., Nguyen, Tammy, Dema-Ala, Rhanika, Kummel, Andrew C., Kipps, Thomas J., Messmer, Bradley T.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921063/
https://www.ncbi.nlm.nih.gov/pubmed/20087593
http://dx.doi.org/10.1007/s00280-009-1240-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921063/
https://www.ncbi.nlm.nih.gov/pubmed/20087593
http://dx.doi.org/10.1007/s00280-009-1240-1

Ejemplares similares